Study of R-3750 for late-stage acute respiratory distress syndrome
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests an experimental drug called R-3750 for people with a severe lung condition called ARDS that has not improved after at least a week. The drug is given through a tube into the stomach, and the goal is to see if it can help the lungs recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been on a breathing machine (ventilator) for at least 7 days because of ARDS.
- Your ARDS has not improved, and you still need significant breathing support.
- You can receive the study drug through a tube into your stomach (like a feeding tube).
- You are not pregnant or breastfeeding.
- You have not taken part in another experimental drug study in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine (LEAF-4L6715) for people with acute respiratory distress syndrome (ARDS), a serious lung condition. The aim is to see if this medicine helps improve breathing and recovery in people on a breathing machine. The trial is for adults who have had ARDS for at least 24 hours and are already on a breathing machine.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This Phase 2 trial tests Rhu-pGSN in adults with acute respiratory distress syndrome (ARDS) caused by an infection. If you qualify, the study may help determine whether the drug improves outcomes in this short-term, life-threatening lung condition.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
This study tests an experimental medicine called R-3750 to see if it is safe and helpful for people with mild to moderate COPD. It is an early-phase trial, so the main goal is safety, but they will also look at how your breathing responds.
This trial tests a new medicine called GKL-006RTU for people with moderate to severe ARDS caused by an infection. The goal is to see if it is safe and helps improve breathing and recovery.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.